GEN Exclusives

More »

GEN News Highlights

More »
Jan 4, 2007

SeqWright to Perform Sequencing and Analysis for Third Wave HPV Trial

  • Third Wave Technologies selected SeqWright to participate in the clinical trial for two human papillomavirus (HPV) screening products.

    SeqWright will perform all the sequencing and associated analyses in support of Third Wave’s HPV trial for evaluation of two new in vitro diagnostic molecular assays: a screening test for the detection of 14 high-risk types of HPV and a genotyping test to specifically detect and identify HPV types 16 and 18. These two HPV types have been identified as the cause of approximately 70% of cervical cancer cases.

    SeqWright's participation in this clinical trial will enable development and implementation of custom sequence analysis procedures, according to the companies.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?